Sunday 11 October 2026 Export all VXRT data to Excel Powerpack

VAXART, INC.

VAXART, INC.’s revenue for fiscal 2025 (year ended December 2025) was $237.3 million, up 726.7% from fiscal 2024. In the quarter to June 2026, revenue fell 31.6%, EPS grew 14.3% and free cash flow grew 117.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

0.43 0.00 0.00%

Follow VXRT

Alert me

Market cap: $92.4M
P/E: 2.8×
Fwd P/E: 2.1×
Dividend yield: —
F-score: 6/9
Altman Z: −1.06
Beneish M: 3.73
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

VAXART, INC. (VXRT) P/E ratio

Alert me on P/E ratio

As of 9 October 2026, VAXART, INC. (VXRT) trades at a P/E ratio of 2.8×. Over the past ten years it has ranged from 0.0× (December 2025) to 35.6× (January 2015); the current reading is higher than 87% of that period. That is below the Biotechnology industry median of 8.7× and below the Healthcare sector median of 22.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/VXRT/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="VAXART, INC. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/VXRT/metrics/pe-ratio">VAXART, INC. (VXRT) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	5.8×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2017	0.0×	—

Period	P/E ratio	Change
Jun 2026	3.8×	(6.25%)
Mar 2026	4.1×	(30.28%)
Dec 2025	5.8×	—
Sep 2025	0.0×	—
38 more quarters	Free account

Against its own ten years

Low 0.0× High 35.6×

Ten-year median 0.0×

Current reading's percentile 87

Company	P/E ratio
MIST Milestone Pharmaceuticals Inc. compare	n/m
OKUR OnKure Therapeutics, Inc. compare	n/m
EQ Equillium, Inc. compare	n/m
CLLS Cellectis S.A. compare	n/m
NMRA Neumora Therapeutics, Inc. compare	n/m
ATRA Atara Biotherapeutics, Inc. compare	n/m
RLYB Rallybio Corporation compare	2.1×
VXRT VAXART, INC.	2.8×
ICCC ImmuCell Corporation compare	114×
Biotechnology industry median	8.7×
Healthcare sector median	22.5×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

VAXART, INC. (VXRT) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on VXRT

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on VXRT

Stockrow Weekly